Femasys CFO buys stock and receives new warrants
Femasys Inc. Chief Financial Officer Dov Elefant reported new equity transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Femasys Inc. Chief Financial Officer Dov Elefant reported new equity transactions. On August 7, 2026, he purchased 15,625 shares of common stock at $3.20 per share for an aggregate $50,000 under a Securities Purchase Agreement. He also received two direct grants of common stock purchase warrants, each for 15,625 shares at an exercise price of $2.95 per share. One warrant is exercisable from August 10, 2026 until August 10, 2029, subject to Nasdaq Capital Market limitations. The milestone warrant becomes exercisable only after a future Milestone Date tied to achieving $1,500,000 in U.S. quarterly revenue and specified volume-weighted average price conditions.
Insider Trade Summary
Net Buyer: 15,625 shares
Net Buy
3 txns
Insider
Elefant Dov
Role
Chief Financial Officer
Bought
15,625 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Purchase Warrant F2, F4, F3 | 15,625 | -- | -- |
| Grant/Award | Common Stock Purchase Warrant (Milestone) F2, F4, F5, F3 | 15,625 | -- | -- |
| Purchase | Common Stock F1 | 15,625 | $3.20 | $50K |
Holdings After Transaction:
Common Stock Purchase Warrant — 15,625 contracts (Direct);
Common Stock Purchase Warrant (Milestone) — 15,625 contracts (Direct);
Common Stock — 15,625 shares (Direct)
Footnotes (5)
- F1. The purchase price paid by the reporting person for the Shares was $3.20 per share pursuant to the Securities Purchase Agreement, dated as of August 7, 2026, by and among Femasys Inc. and the purchasers party thereto.
- F2. Holder may, at its option, exercise the Common Warrant, subject to the terms and conditions thereof, at an exercise price of $2.95 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Common Warrant and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- F3. The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
- F4. The reported securities were purchased by the reporting person for an aggregate amount of $50,000.
- F5. The Common Warrant (Milestone) is exercisable only from and after the Milestone Date, being the first date on or after August 10, 2027 on which both (i) the Company has achieved U.S. revenue of $1,500,000 for any fiscal quarter, as reported in a Form 10-Q or Form 10-K, and (ii) the volume-weighted average price of the Common Stock has satisfied certain price conditions specified in the warrant. The warrant expires on the earlier of (i) three years after the effective date of a registration statement registering the resale of the Warrant Shares and (ii) 45 days after the Company delivers notice that the Milestone Date has occurred. As of the date of this report, neither the Milestone Date nor the expiration date is determinable.
Key Figures
Common shares purchased: 15,625 shares
Purchase price per share: $3.20 per share
Aggregate purchase amount: $50,000
+4 more
7 metrics
Common shares purchased
15,625 shares
Common Stock purchased on August 7, 2026
Purchase price per share
$3.20 per share
Price for common stock under Securities Purchase Agreement
Aggregate purchase amount
$50,000
Aggregate amount paid for reported securities
Warrant exercise price
$2.95 per share
Exercise price of common stock purchase warrants
Standard warrant shares
15,625 shares
Underlying common shares for standard warrant grant
Milestone warrant shares
15,625 shares
Underlying common shares for milestone warrant grant
Revenue milestone
$1,500,000
U.S. revenue for any fiscal quarter required for Milestone Date
Key Terms
Common Stock Purchase Warrant, Milestone Date, volume-weighted average price, Nasdaq Capital Market
4 terms
Common Stock Purchase Warrant financial
"Holder may, at its option, exercise the Common Warrant"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Milestone Date financial
"The Common Warrant (Milestone) is exercisable only from and after the Milestone Date"
volume-weighted average price financial
"the volume-weighted average price of the Common Stock has satisfied certain price conditions"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
Nasdaq Capital Market financial
"subject to certain limitations, in accordance with rules of the Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Femasys (FEMY) CFO Dov Elefant buy in this Form 4 filing?
Femasys CFO Dov Elefant purchased 15,625 shares of common stock at $3.20 per share. The total purchase price was $50,000, made under a Securities Purchase Agreement dated August 7, 2026 with Femasys Inc. and other purchasers.
What warrants were granted to the Femasys (FEMY) CFO in this transaction?
He was granted two common stock purchase warrants, each for 15,625 shares at an exercise price of $2.95 per share. One is a standard warrant, and the other is a milestone-based warrant with additional performance and price conditions.
When can the Femasys (FEMY) standard warrant granted to the CFO be exercised?
The standard common stock purchase warrant for 15,625 shares is exercisable, at the holder’s option, from August 10, 2026 until August 10, 2029, subject to limitations described as being in accordance with Nasdaq Capital Market rules.
What conditions govern the milestone warrant in the Femasys (FEMY) CFO Form 4?
The milestone warrant becomes exercisable only after a Milestone Date when Femasys reports $1,500,000 or more in U.S. revenue for any fiscal quarter and the stock’s volume-weighted average price satisfies warrant-specified conditions, with its expiration tied to registration and milestone notice timing.
Are there limitations on exercising the Femasys (FEMY) warrants granted to the CFO?
Yes. A footnote states the holder’s ability to exercise the warrant for common stock is subject to certain limitations under Nasdaq Capital Market rules. These limitations apply to the subject warrant’s exercise for shares of common stock.
What total dollar amount did the Femasys (FEMY) CFO invest in these reported securities?
The reported securities were purchased for an aggregate amount of $50,000. This aggregate figure applies to the securities described, including the common stock purchased at $3.20 per share as referenced in the Securities Purchase Agreement footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates